Pediatric MRI Market Analysis, Scope, and Growth by 2028
Pediatric MRI Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 3.66 Billion |
Market Size by 2028 | US$ 5.68 Billion |
Global CAGR (2022 - 2028) | 7.6% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
Recent Developments:
Inorganic and organic strategies such as mergers and acquisitions are highly adopted by companies in the pediatric MRI market. A few recent key market developments are listed below:
- In March 2023, Time Medical officially opened its new Hong Kong production facility at the MARS Centre at Tai Po INNOPARK, becoming the first large-scale medical equipment production facility in Hong Kong and the largest MRI production base in the Greater Bay Area and Southeast Asia. The production facility specializes in R&D and production of high value-add neonatal and breast screening superconductor MRI systems.
- In February 2023, Hyperfine, Inc. received CE Marking for the Swoop system, the world's first FDA-cleared portable MRI system. While the company maintains its commercial focus on the US, CE Marking opens the door for potential commercial expansion into the European Economic Area (EEA).
- In February 2023, Time Medical received US FDA approval for its neonatal MRI system, NEONA. It is the world-first superconducting MRI system dedicated to pediatric diagnosis and can significantly improve the precision and image quality of fragile newborns, infants, and children. This innovation is lightweight and compact to fit inside a NICU, greatly reducing the health risk of moving young patients around.
- In June 2022, Hyperfine, Inc. received the FDA 510(k) clearance and launched the Swoop system new sequences, expanding the system's capabilities, and allowing shorter brain scan times for patients. The system’s new software uses deep learning to deliver crisp, clear images that aid in clinical diagnosis.
- In June 2022, Hyperfine, Inc. completed registration and notification of the Swoop device in Australia and New Zealand. With this activity, the Swoop system is now available for purchase in both countries and includes the US FDA-cleared advanced reconstruction software using deep learning. Quantum HealthCare became the company’s product distributor for Australia and New Zealand.